LIXTW
USDLixte Biotechnology Holdings Inc. Warrants
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$0.030
Haut
$0.030
Bas
$0.030
Volume
0.00M
Fondamentaux de l'Entreprise
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
0.00M
Bourse
NCM
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
LIXTE Launches New Study to Determine if Certain Pre-Cancerous Cells Found in an Aging Population Can Be Eliminated by LB-100
Pre-Clinical Study in Collaboration with Netherlands Cancer Instituteis in addition to LIXTE's Ongoing Clinical Trials for Ovarian and Colorectal Cancers PASADENA, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- LIXTE
LIXTE Biotechnology Provides Update On Progress with Proprietary Compound, LB-100, to Treat Ovarian and Colorectal Cancer
-Started Two New Clinical Trials, Collaborating with MD Anderson and The Netherlands Cancer Institute for Treatment of Ovarian and Colorectal Cancer- -Received Exclusive Patent License Agreement with the NIH on
Actions Connexes
URGN
UroGen Pharma Ltd. Ordinary Shares
KF
Korea Fund Inc. (The) New
FGB
First Trust Specialty Finance and Financial Opportunities Fund
DTIL
Precision BioSciences Inc.
OFS
OFS Capital Corporation
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.